SYQ_HUMAN - dbPTM
SYQ_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID SYQ_HUMAN
UniProt AC P47897
Protein Name Glutamine--tRNA ligase
Gene Name QARS
Organism Homo sapiens (Human).
Sequence Length 775
Subcellular Localization Cytoplasm, cytosol . Cytoplasm .
Protein Description Glutamine--tRNA ligase. [PubMed: 26869582 Plays a critical role in brain development]
Protein Sequence MAALDSLSLFTSLGLSEQKARETLKNSALSAQLREAATQAQQTLGSTIDKATGILLYGLASRLRDTRRLSFLVSYIASKKIHTEPQLSAALEYVRSHPLDPIDTVDFERECGVGVIVTPEQIEEAVEAAINRHRPQLLVERYHFNMGLLMGEARAVLKWADGKMIKNEVDMQVLHLLGPKLEADLEKKFKVAKARLEETDRRTAKDVVENGETADQTLSLMEQLRGEALKFHKPGENYKTPGYVVTPHTMNLLKQHLEITGGQVRTRFPPEPNGILHIGHAKAINFNFGYAKANNGICFLRFDDTNPEKEEAKFFTAICDMVAWLGYTPYKVTYASDYFDQLYAWAVELIRRGLAYVCHQRGEELKGHNTLPSPWRDRPMEESLLLFEAMRKGKFSEGEATLRMKLVMEDGKMDPVAYRVKYTPHHRTGDKWCIYPTYDYTHCLCDSIEHITHSLCTKEFQARRSSYFWLCNALDVYCPVQWEYGRLNLHYAVVSKRKILQLVATGAVRDWDDPRLFTLTALRRRGFPPEAINNFCARVGVTVAQTTMEPHLLEACVRDVLNDTAPRAMAVLESLRVIITNFPAAKSLDIQVPNFPADETKGFHQVPFAPIVFIERTDFKEEPEPGFKRLAWGQPVGLRHTGYVIELQHVVKGPSGCVESLEVTCRRADAGEKPKAFIHWVSQPLMCEVRLYERLFQHKNPEDPTEVPGGFLSDLNLASLHVVDAALVDCSVALAKPFDKFQFERLGYFSVDPDSHQGKLVFNRTVTLKEDPGKV
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAALDSLSL
------CCHHHHHHH
19.4122223895
6Phosphorylation--MAALDSLSLFTSL
--CCHHHHHHHHHHC
22.2520068231
8PhosphorylationMAALDSLSLFTSLGL
CCHHHHHHHHHHCCC
25.9528348404
11PhosphorylationLDSLSLFTSLGLSEQ
HHHHHHHHHCCCCHH
28.4720068231
12PhosphorylationDSLSLFTSLGLSEQK
HHHHHHHHCCCCHHH
17.0728348404
16PhosphorylationLFTSLGLSEQKARET
HHHHCCCCHHHHHHH
35.8620068231
23PhosphorylationSEQKARETLKNSALS
CHHHHHHHHHHHHHH
37.1626552605
25UbiquitinationQKARETLKNSALSAQ
HHHHHHHHHHHHHHH
57.1721906983
25MalonylationQKARETLKNSALSAQ
HHHHHHHHHHHHHHH
57.1726320211
25UbiquitinationQKARETLKNSALSAQ
HHHHHHHHHHHHHHH
57.17-
27PhosphorylationARETLKNSALSAQLR
HHHHHHHHHHHHHHH
29.0623911959
30PhosphorylationTLKNSALSAQLREAA
HHHHHHHHHHHHHHH
17.4323312004
43PhosphorylationAATQAQQTLGSTIDK
HHHHHHHHHHHHHHH
22.4729255136
46PhosphorylationQAQQTLGSTIDKATG
HHHHHHHHHHHHHHH
25.8829255136
47PhosphorylationAQQTLGSTIDKATGI
HHHHHHHHHHHHHHH
31.2529255136
50UbiquitinationTLGSTIDKATGILLY
HHHHHHHHHHHHHHH
43.95-
57PhosphorylationKATGILLYGLASRLR
HHHHHHHHHHHHCCC
13.4728152594
61PhosphorylationILLYGLASRLRDTRR
HHHHHHHHCCCHHHH
36.5728152594
66PhosphorylationLASRLRDTRRLSFLV
HHHCCCHHHHHHHHH
15.9729083192
70PhosphorylationLRDTRRLSFLVSYIA
CCHHHHHHHHHHHHH
18.0922617229
74PhosphorylationRRLSFLVSYIASKKI
HHHHHHHHHHHCCCC
16.9930108239
74 (in isoform 2)Phosphorylation-16.9928122231
75PhosphorylationRLSFLVSYIASKKIH
HHHHHHHHHHCCCCC
7.9427282143
75 (in isoform 2)Phosphorylation-7.9428122231
78PhosphorylationFLVSYIASKKIHTEP
HHHHHHHCCCCCCCH
25.5623312004
78 (in isoform 2)Phosphorylation-25.5628122231
802-HydroxyisobutyrylationVSYIASKKIHTEPQL
HHHHHCCCCCCCHHH
36.91-
82 (in isoform 2)Phosphorylation-32.8128122231
88PhosphorylationIHTEPQLSAALEYVR
CCCCHHHHHHHHHHH
13.27-
93PhosphorylationQLSAALEYVRSHPLD
HHHHHHHHHHHCCCC
11.30-
142PhosphorylationPQLLVERYHFNMGLL
HHHEEEEEECCHHHH
9.3928258704
155UbiquitinationLLMGEARAVLKWADG
HHHHHHHHHHHHCCC
20.31-
158AcetylationGEARAVLKWADGKMI
HHHHHHHHHCCCCCC
33.4626051181
163UbiquitinationVLKWADGKMIKNEVD
HHHHCCCCCCCCCCH
37.69-
166UbiquitinationWADGKMIKNEVDMQV
HCCCCCCCCCCHHHH
43.48-
171SulfoxidationMIKNEVDMQVLHLLG
CCCCCCHHHHHHHHC
3.4221406390
176UbiquitinationVDMQVLHLLGPKLEA
CHHHHHHHHCHHHHH
5.31-
180UbiquitinationVLHLLGPKLEADLEK
HHHHHCHHHHHHHHH
58.10-
1872-HydroxyisobutyrylationKLEADLEKKFKVAKA
HHHHHHHHHHHHHHH
71.46-
187UbiquitinationKLEADLEKKFKVAKA
HHHHHHHHHHHHHHH
71.46-
194UbiquitinationKKFKVAKARLEETDR
HHHHHHHHHHHHHCC
16.14-
201MethylationARLEETDRRTAKDVV
HHHHHHCCCCHHHHH
45.31115489755
205UbiquitinationETDRRTAKDVVENGE
HHCCCCHHHHHHCCC
50.9021906983
213PhosphorylationDVVENGETADQTLSL
HHHHCCCCHHHHHHH
36.6128555341
217PhosphorylationNGETADQTLSLMEQL
CCCCHHHHHHHHHHH
20.8928555341
222UbiquitinationDQTLSLMEQLRGEAL
HHHHHHHHHHCCHHH
52.32-
225MethylationLSLMEQLRGEALKFH
HHHHHHHCCHHHHCC
40.37115489763
228UbiquitinationMEQLRGEALKFHKPG
HHHHCCHHHHCCCCC
20.90-
230UbiquitinationQLRGEALKFHKPGEN
HHCCHHHHCCCCCCC
53.09-
233UbiquitinationGEALKFHKPGENYKT
CHHHHCCCCCCCCCC
58.83-
239UbiquitinationHKPGENYKTPGYVVT
CCCCCCCCCCCEEEC
60.88-
240PhosphorylationKPGENYKTPGYVVTP
CCCCCCCCCCEEECH
16.1623312004
243UbiquitinationENYKTPGYVVTPHTM
CCCCCCCEEECHHHH
7.92-
243PhosphorylationENYKTPGYVVTPHTM
CCCCCCCEEECHHHH
7.9223312004
246PhosphorylationKTPGYVVTPHTMNLL
CCCCEEECHHHHHHH
10.1823312004
249PhosphorylationGYVVTPHTMNLLKQH
CEEECHHHHHHHHHH
14.6823312004
254MethylationPHTMNLLKQHLEITG
HHHHHHHHHHHEECC
38.5554411627
254UbiquitinationPHTMNLLKQHLEITG
HHHHHHHHHHHEECC
38.55-
281UbiquitinationGILHIGHAKAINFNF
CEEEEEECEEEEEEC
9.58-
290PhosphorylationAINFNFGYAKANNGI
EEEEECEEEECCCCE
10.7828152594
292UbiquitinationNFNFGYAKANNGICF
EEECEEEECCCCEEE
43.07-
309AcetylationFDDTNPEKEEAKFFT
ECCCCHHHHHHHHHH
63.2119608861
355AcetylationELIRRGLAYVCHQRG
HHHHHHHHHHHHHCC
9.50-
355UbiquitinationELIRRGLAYVCHQRG
HHHHHHHHHHHHHCC
9.50-
366AcetylationHQRGEELKGHNTLPS
HHCCCCCCCCCCCCC
62.4923236377
366MalonylationHQRGEELKGHNTLPS
HHCCCCCCCCCCCCC
62.4926320211
366UbiquitinationHQRGEELKGHNTLPS
HHCCCCCCCCCCCCC
62.4921906983
370PhosphorylationEELKGHNTLPSPWRD
CCCCCCCCCCCCCCC
34.0820873877
373PhosphorylationKGHNTLPSPWRDRPM
CCCCCCCCCCCCCCH
39.9620873877
381UbiquitinationPWRDRPMEESLLLFE
CCCCCCHHHHHHHHH
47.30-
383UbiquitinationRDRPMEESLLLFEAM
CCCCHHHHHHHHHHH
15.83-
392UbiquitinationLLFEAMRKGKFSEGE
HHHHHHHCCCCCCCC
54.06-
394UbiquitinationFEAMRKGKFSEGEAT
HHHHHCCCCCCCCCE
49.07-
3942-HydroxyisobutyrylationFEAMRKGKFSEGEAT
HHHHHCCCCCCCCCE
49.07-
394AcetylationFEAMRKGKFSEGEAT
HHHHHCCCCCCCCCE
49.0725953088
394UbiquitinationFEAMRKGKFSEGEAT
HHHHHCCCCCCCCCE
49.0721906983
401AcetylationKFSEGEATLRMKLVM
CCCCCCCEEEEEEEE
15.59-
401UbiquitinationKFSEGEATLRMKLVM
CCCCCCCEEEEEEEE
15.59-
405UbiquitinationGEATLRMKLVMEDGK
CCCEEEEEEEEECCC
31.34-
4122-HydroxyisobutyrylationKLVMEDGKMDPVAYR
EEEEECCCCCCEEEE
53.07-
412AcetylationKLVMEDGKMDPVAYR
EEEEECCCCCCEEEE
53.0723954790
412MalonylationKLVMEDGKMDPVAYR
EEEEECCCCCCEEEE
53.0726320211
412UbiquitinationKLVMEDGKMDPVAYR
EEEEECCCCCCEEEE
53.0721906983
420UbiquitinationMDPVAYRVKYTPHHR
CCCEEEEEEECCCCC
3.46-
421AcetylationDPVAYRVKYTPHHRT
CCEEEEEEECCCCCC
34.1125953088
421UbiquitinationDPVAYRVKYTPHHRT
CCEEEEEEECCCCCC
34.11-
431UbiquitinationPHHRTGDKWCIYPTY
CCCCCCCEEEECCCC
45.36-
447UbiquitinationYTHCLCDSIEHITHS
CCHHHHHHHHHHCHH
28.95-
477PhosphorylationLCNALDVYCPVQWEY
HHHHHCEECCEEEEE
7.2422817900
484PhosphorylationYCPVQWEYGRLNLHY
ECCEEEEECCEEEEE
12.4622817900
485UbiquitinationCPVQWEYGRLNLHYA
CCEEEEECCEEEEEE
18.98-
491PhosphorylationYGRLNLHYAVVSKRK
ECCEEEEEEEEEHHH
12.3121082442
495PhosphorylationNLHYAVVSKRKILQL
EEEEEEEEHHHHHHH
21.8328152594
4962-HydroxyisobutyrylationLHYAVVSKRKILQLV
EEEEEEEHHHHHHHH
46.21-
496AcetylationLHYAVVSKRKILQLV
EEEEEEEHHHHHHHH
46.2126051181
496UbiquitinationLHYAVVSKRKILQLV
EEEEEEEHHHHHHHH
46.21-
498AcetylationYAVVSKRKILQLVAT
EEEEEHHHHHHHHHH
52.0530585951
498MalonylationYAVVSKRKILQLVAT
EEEEEHHHHHHHHHH
52.0526320211
505PhosphorylationKILQLVATGAVRDWD
HHHHHHHHCCCCCCC
20.4220068231
518PhosphorylationWDDPRLFTLTALRRR
CCCCHHHHHHHHHHC
27.9922210691
520PhosphorylationDPRLFTLTALRRRGF
CCHHHHHHHHHHCCC
22.1620873877
556GlutathionylationEPHLLEACVRDVLND
CHHHHHHHHHHHHCC
1.5622555962
564PhosphorylationVRDVLNDTAPRAMAV
HHHHHCCCHHHHHHH
37.1720071362
569SulfoxidationNDTAPRAMAVLESLR
CCCHHHHHHHHHHCH
2.5321406390
575AcetylationAMAVLESLRVIITNF
HHHHHHHCHHHCCCC
3.56-
575UbiquitinationAMAVLESLRVIITNF
HHHHHHHCHHHCCCC
3.56-
586AcetylationITNFPAAKSLDIQVP
CCCCCCCCCCCEECC
54.3723236377
586UbiquitinationITNFPAAKSLDIQVP
CCCCCCCCCCCEECC
54.3721906983
590UbiquitinationPAAKSLDIQVPNFPA
CCCCCCCEECCCCCC
5.58-
601UbiquitinationNFPADETKGFHQVPF
CCCCCCCCCCCCCCC
58.49-
609AcetylationGFHQVPFAPIVFIER
CCCCCCCCCEEEEEC
6.19-
609UbiquitinationGFHQVPFAPIVFIER
CCCCCCCCCEEEEEC
6.19-
617AcetylationPIVFIERTDFKEEPE
CEEEEECCCCCCCCC
32.76-
617UbiquitinationPIVFIERTDFKEEPE
CEEEEECCCCCCCCC
32.76-
620AcetylationFIERTDFKEEPEPGF
EEECCCCCCCCCCCC
65.0723954790
620MalonylationFIERTDFKEEPEPGF
EEECCCCCCCCCCCC
65.0726320211
620UbiquitinationFIERTDFKEEPEPGF
EEECCCCCCCCCCCC
65.0721906983
628AcetylationEEPEPGFKRLAWGQP
CCCCCCCEECCCCCC
53.0323749302
628MalonylationEEPEPGFKRLAWGQP
CCCCCCCEECCCCCC
53.0326320211
628MethylationEEPEPGFKRLAWGQP
CCCCCCCEECCCCCC
53.0311924111
628UbiquitinationEEPEPGFKRLAWGQP
CCCCCCCEECCCCCC
53.03-
641UbiquitinationQPVGLRHTGYVIELQ
CCCCCCCCEEEEEEE
24.63-
657GlutathionylationVVKGPSGCVESLEVT
EEECCCCCEEEEEEE
3.4422555962
673UbiquitinationRRADAGEKPKAFIHW
ECCCCCCCCCEEEHH
51.40-
687GlutathionylationWVSQPLMCEVRLYER
HHCCCHHHHHHHHHH
6.0322555962
7402-HydroxyisobutyrylationALAKPFDKFQFERLG
HCCCCCCCCCCEECC
41.25-
740AcetylationALAKPFDKFQFERLG
HCCCCCCCCCCEECC
41.2527452117
740UbiquitinationALAKPFDKFQFERLG
HCCCCCCCCCCEECC
41.25-
748UbiquitinationFQFERLGYFSVDPDS
CCCEECCCEEECCCC
9.40-
748PhosphorylationFQFERLGYFSVDPDS
CCCEECCCEEECCCC
9.4028152594
758AcetylationVDPDSHQGKLVFNRT
ECCCCCCCEEEEEEE
21.60-
758UbiquitinationVDPDSHQGKLVFNRT
ECCCCCCCEEEEEEE
21.60-
759AcetylationDPDSHQGKLVFNRTV
CCCCCCCEEEEEEEE
34.6025953088
759UbiquitinationDPDSHQGKLVFNRTV
CCCCCCCEEEEEEEE
34.60-
763UbiquitinationHQGKLVFNRTVTLKE
CCCEEEEEEEEEECC
31.10-
765PhosphorylationGKLVFNRTVTLKEDP
CEEEEEEEEEECCCC
20.9629514088
767PhosphorylationLVFNRTVTLKEDPGK
EEEEEEEEECCCCCC
31.3429514088
769AcetylationFNRTVTLKEDPGKV-
EEEEEEECCCCCCC-
51.1923749302
769MalonylationFNRTVTLKEDPGKV-
EEEEEEECCCCCCC-
51.1926320211
769UbiquitinationFNRTVTLKEDPGKV-
EEEEEEECCCCCCC-
51.192190698
774UbiquitinationTLKEDPGKV------
EECCCCCCC------
50.59-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of SYQ_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of SYQ_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of SYQ_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
TRAF2_HUMANTRAF2physical
16189514
A4_HUMANAPPphysical
21832049
SYRC_HUMANRARSphysical
22939629
UBA1_HUMANUBA1physical
22939629
TRM1_HUMANTRMT1physical
22939629
TXLNA_HUMANTXLNAphysical
22939629
ZFR_HUMANZFRphysical
22939629
RNF11_HUMANRNF11physical
21988832
AIMP1_HUMANAIMP1physical
22863883
AIMP2_HUMANAIMP2physical
22863883
IF2G_HUMANEIF2S3physical
22863883
ROA1_HUMANHNRNPA1physical
22863883
ROA2_HUMANHNRNPA2B1physical
22863883
SYIC_HUMANIARSphysical
22863883
IF2B3_HUMANIGF2BP3physical
22863883
IQGA1_HUMANIQGAP1physical
22863883
CCAR2_HUMANCCAR2physical
22863883
SYMC_HUMANMARSphysical
22863883
MRE11_HUMANMRE11Aphysical
22863883
NMT1_HUMANNMT1physical
22863883
PRS10_HUMANPSMC6physical
22863883
PTBP1_HUMANPTBP1physical
22863883
TBB2A_HUMANTUBB2Aphysical
22863883
SYVC_HUMANVARSphysical
22863883
HTF4_HUMANTCF12physical
25416956
PCH2_HUMANTRIP13physical
25416956
TRAF4_HUMANTRAF4physical
25416956
VP37B_HUMANVPS37Bphysical
25416956
LZTS2_HUMANLZTS2physical
25416956
DTX2_HUMANDTX2physical
25416956
KLC3_HUMANKLC3physical
25416956
MCA3_HUMANEEF1E1physical
26344197
SYEP_HUMANEPRSphysical
26344197
PLEC_HUMANPLECphysical
26344197
TRM6_HUMANTRMT6physical
26344197
SYRC_HUMANRARSphysical
28514442
MCA3_HUMANEEF1E1physical
28514442
AIMP2_HUMANAIMP2physical
28514442
AIMP1_HUMANAIMP1physical
28514442
SYDC_HUMANDARSphysical
28514442
SYLC_HUMANLARSphysical
28514442
SYEP_HUMANEPRSphysical
28514442
SYIC_HUMANIARSphysical
28514442
SYMC_HUMANMARSphysical
28514442
OFD1_HUMANOFD1physical
27173435

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
615760Microcephaly, progressive, with seizures and cerebral and cerebellar atrophy (MSCCA)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
DB00130L-Glutamine
Regulatory Network of SYQ_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-309 AND LYS-620, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70, AND MASSSPECTROMETRY.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-491, AND MASSSPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-491, AND MASSSPECTROMETRY.

TOP